Hims & Hers Soars on Reduced Price Deal for Novo's Wegovy
Hims & Hers Health surged after Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a reduced price on several telehealth platforms at a 63% discount from the drug's US list price, before additional subscription fees. Madison Muller reports on Bloomberg Television.
Terms and Privacy Policy